Junctional adhesion molecule-A suppresses platelet integrin αIIbβ3 signaling by recruiting Csk to the integrin-c-Src complex

Blood

Volumn 123, Issue 9, 2014, Pages 1393-1402

  Naik, Meghna U ^a   Caplan, Jeffrey L ^a   Naik, Ulhas P ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B BETA3 INTEGRIN; C TERMINAL SRC KINASE; INTEGRIN; JUNCTIONAL ADHESION MOLECULE A; PHOSPHOTRANSFERASE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CSK TYROSINE PROTEIN KINASE; CSK TYROSINE-PROTEIN KINASE; F11R PROTEIN, HUMAN; FIBRINOGEN RECEPTOR; MULTIPROTEIN COMPLEX; PROTEIN KINASE P60;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; ADOLESCENT; ADULT; ANIMAL; CELL CULTURE; DOWN REGULATION; KNOCKOUT MOUSE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; THROMBOCYTE; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; BLOOD PLATELETS; CELL ADHESION MOLECULES; CELLS, CULTURED; DOWN-REGULATION; HUMANS; MICE; MICE, KNOCKOUT; MULTIPROTEIN COMPLEXES; PHOSPHORYLATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; YOUNG ADULT;

EID: 84899677468     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-04-496232     Document Type: Article

References (50)

1. Shattil SJ. Signaling through platelet integrin alpha IIb beta 3: inside-out, outside-in, and sideways. Thromb Haemost. 1999;82(2):318-325.
2. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110(6):673-687. (Pubitemid 35283958)
3. Shattil SJ, Kashiwagi H, Pampori N. Integrin signaling: the platelet paradigm. Blood. 1998;91(8):2645-2657. (Pubitemid 28227512)
4. Jones CI, Barrett NE, Moraes LA, Gibbins JM, Jackson DE. Endogenous inhibitory mechanisms and the regulation of platelet function. Methods Mol Biol. 2012;788:341-366.
5. Inoue O, Suzuki-Inoue K, Dean WL, Frampton J, Watson SP. Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2. J Cell Biol. 2003;160(5):769-780. (Pubitemid 36298271)
6. Kaplan KB, Swedlow JR, Morgan DO, Varmus HE. c-Src enhances the spreading of src-/- fibroblasts on fibronectin by a kinase-independent mechanism. Genes Dev. 1995;9(12):1505-1517.
7. Obergfell A, Eto K, Mocsai A, et al. Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton. J Cell Biol. 2002;157(2):265-275. (Pubitemid 34839823)
8. Brown MT, Cooper JA. Regulation, substrates and functions of src. Biochim Biophys Acta. 1996;1287(2-3):121-149. (Pubitemid 26189191)
9. Superti-Furga G. Regulation of the Src protein tyrosine kinase. FEBS Lett. 1995;369(1):62-66.
10. Weijland A, Williams JC, Neubauer G, Courtneidge SA, Wierenga RK, Superti-Furga G. Src regulated by C-terminal phosphorylation is monomeric. Proc Natl Acad Sci USA. 1997;94(8):3590-3595. (Pubitemid 27180416)
11. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol. 1997;13:513-609. (Pubitemid 28034534)
12. Chong YP, Mulhern TD, Cheng HC. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)-endogenous negative regulators of Srcfamily protein kinases. Growth Factors. 2005;23(3):233-244. (Pubitemid 43203054)
13. Howell BW, Cooper JA. Csk suppression of Src involves movement of Csk to sites of Src activity. Mol Cell Biol. 1994;14(8):5402-5411. (Pubitemid 24235968)
14. Sabe H, Hata A, Okada M, Nakagawa H, Hanafusa H. Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src. Proc Natl Acad Sci USA. 1994;91(9):3984-3988.
15. Grgurevich S, Mikhael A, McVicar DW. The Csk homologous kinase, Chk, binds tyrosine phosphorylated paxillin in human blastic T cells. Biochem Biophys Res Commun. 1999;256(3):668-675. (Pubitemid 29301165)
16. Rathore VB, Okada M, Newman PJ, Newman DK. Paxillin family members function as Csk-binding proteins that regulate Lyn activity in human and murine platelets. Biochem J. 2007;403(2):275-281. (Pubitemid 46596583)
17. Kralisz U, Cierniewski CS. Association of pp60c-src with alpha IIb beta 3 in resting platelets. Biochem Mol Biol Int. 1998;45(4):735-743. (Pubitemid 28393541)
18. Aurrand-Lions M, Johnson-Leger C, Wong C, Du Pasquier L, Imhof BA. Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood. 2001;98(13):3699-3707.
19. Naik UP, Ehrlich YH, Kornecki E. Mechanisms of platelet activation by a stimulatory antibody: cross-linking of a novel platelet receptor for monoclonal antibody F11 with the Fc gamma RII receptor. Biochem J. 1995;310(Pt 1):155-162.
20. Ozaki H, Ishii K, Arai H, et al. Junctional adhesion molecule (JAM) is phosphorylated by protein kinase C upon platelet activation. Biochem Biophys Res Commun. 2000;276(3):873-878.
21. 3-dependent outside-in signaling in platelets. Blood. 2012;119(14):3352-3360.
22. Mustard JF, Perry DW, Ardlie NG, Packham MA. Preparation of suspensions of washed platelets from humans. Br J Haematol. 1972;22(2):193-204.
23. Naik UP, Kornecki E, Ehrlich YH. Phosphorylation and dephosphorylation of human platelet surface proteins by an ecto-protein kinase/phosphatase system. Biochim Biophys Acta. 1991;1092(2):256-264.
24. Cooke VG, Naik MU, Naik UP. Fibroblast growth factor-2 failed to induce angiogenesis in junctional adhesion molecule-A-deficient mice. Arterioscler Thromb Vasc Biol. 2006;26(9):2005-2011. (Pubitemid 44253781)
25. Parris JJ, Cooke VG, Skarnes WC, Duncan MK, Naik UP. JAM-A expression during embryonic development. Dev Dyn. 2005;233(4):1517-1524. (Pubitemid 40995149)
26. Naik MU, Nigam A, Manrai P, et al. CIB1 deficiency results in impaired thrombosis: the potential role of CIB1 in outside-in signaling through integrin alpha IIb beta 3. J Thromb Haemost. 2009;7(11):1906-1914.
27. Naik UP, Naik MU, Eckfeld K, Martin-DeLeon P, Spychala J. Characterization and chromosomal localization of JAM-1, a platelet receptor for a stimulatory monoclonal antibody. J Cell Sci. 2001;114(Pt 3):539-547. (Pubitemid 32186111)
28. Naik MU, Vuppalanchi D, Naik UP. Essential role of junctional adhesion molecule-1 in basic fibroblast growth factor-induced endothelial cell migration. Arterioscler Thromb Vasc Biol. 2003;23(12):2165-2171. (Pubitemid 37532315)
29. Naik MU, Naik UP. Contra-regulation of calciumand integrin-binding protein 1-induced cell migration on fibronectin by PAK1 and MAP kinase signaling. J Cell Biochem. 2011;112(11):3289-3299.
30. Vikström E, Bui L, Konradsson P, Magnusson KE. Role of calcium signalling and phosphorylations in disruption of the epithelial junctions by Pseudomonas aeruginosa quorum sensing molecule. Eur J Cell Biol. 2010;89(8):584-597.
31. Naik MU, Naik UP. Junctional adhesion molecule-A-induced endothelial cell migration on vitronectin is integrin alpha v beta 3 specific. J Cell Sci. 2006;119(Pt 3):490-499.
32. Mayer BJ. Signal transduction: clamping down on Src activity. Curr Biol. 1997;7(5):R295-R298. (Pubitemid 27195594)
33. Hanke JH, Gardner JP, Dow RL, et al. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem. 1996;271(2):695-701.
34. Arias-Salgado EG, Lizano S, Sarkar S, Brugge JS, Ginsberg MH, Shattil SJ. Src kinase activation by direct interaction with the integrin beta cytoplasmic domain. Proc Natl Acad Sci USA. 2003;100(23):13298-13302. (Pubitemid 37444736)
35. Hughes PE, Pfaff M. Integrin affinity modulation. Trends Cell Biol. 1998;8(9):359-364. (Pubitemid 28398427)
36. Shattil SJ, Ginsberg MH. Perspectives series: cell adhesion in vascular biology. Integrin signaling in vascular biology. J Clin Invest. 1997;100(1):1-5.
37. Jackson DE, Kupcho KR, Newman PJ. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2. J Biol Chem. 1997;272(40):24868-24875. (Pubitemid 27415660)
38. Jackson DE, Ward CM, Wang R, Newman PJ. The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. Evidence for a mechanistic link between PECAM-1- and integrin-mediated cellular signaling. J Biol Chem. 1997;272(11):6986-6993. (Pubitemid 27166399)
39. Falati S, Patil S, Gross PL, et al. Platelet PECAM-1 inhibits thrombus formation in vivo. Blood. 2006;107(2):535-541. (Pubitemid 43076376)
40. Patil S, Newman DK, Newman PJ. Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen. Blood. 2001;97(6):1727-1732. (Pubitemid 32217240)
41. Rathore V, Stapleton MA, Hillery CA, et al. PECAM-1 negatively regulates GPIb/V/IX signaling in murine platelets. Blood. 2003;102(10):3658-3664. (Pubitemid 37409385)
42. Wong C, Liu Y, Yip J, et al. CEACAM1 negatively regulates platelet-collagen interactions and thrombus growth in vitro and in vivo. Blood. 2009;113(8):1818-1828.
43. Newland SA, Macaulay IC, Floto AR, et al. The novel inhibitory receptor G6B is expressed on the surface of platelets and attenuates platelet function in vitro. Blood. 2007;109(11):4806-4809. (Pubitemid 46827775)
44. Mori J, Pearce AC, Spalton JC, et al. G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2. J Biol Chem. 2008;283(51):35419-35427.
45. Stalker TJ, Wu J, Morgans A, et al. Endothelial cell specific adhesion molecule (ESAM) localizes to platelet-platelet contacts and regulates thrombus formation in vivo. J Thromb Haemost. 2009;7(11):1886-1896.
46. Peddibhotla SS, Brinkmann BF, Kummer D, et al. Tetraspanin CD9 links junctional adhesion molecule-A to av b3 integrin to mediate basic fibroblast growth factor-specific angiogenic signaling. Mol Biol Cell. 2013;24(7):933-944.
47. Ford CE, Furlong MT, Geahlen RL, Harrison ML. Signaling-induced association of a tyrosine-phosphorylated 36-kDa protein with p50csk. J Biol Chem. 1994;269(48):30378-30385.
48. Heit JA, Armasu SM, Petterson T, Rider DN, Cunningham JM, Andrade MD. Association of gene-environment interactions with venous thromboembolism (VTE): a pathway-directed candidate-gene case-control study [abstract]. Blood (ASH Annual Meeting Abstracts). 2010;116(21): Abstract 480.
49. McSherry EA, McGee SF, Jirstrom K, et al. JAMA expression positively correlates with poor prognosis in breast cancer patients. Int J Cancer. 2009;125(6):1343-1351.
50. Naik MU, Naik TU, Suckow AT, Duncan MK, Naik UP. Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion. Cancer Res. 2008;68(7):2194-2203. (Pubitemid 351521792)